| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cell Transformation, Neoplastic | 5 | 2011 | 193 | 0.720 |
Why?
|
| Mitogen-Activated Protein Kinases | 7 | 2004 | 205 | 0.590 |
Why?
|
| Diet, High-Fat | 5 | 2025 | 163 | 0.490 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 9 | 2018 | 127 | 0.460 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2018 | 411 | 0.420 |
Why?
|
| Obesity | 5 | 2025 | 1166 | 0.420 |
Why?
|
| ras Proteins | 2 | 2003 | 77 | 0.410 |
Why?
|
| Signal Transduction | 12 | 2025 | 2888 | 0.390 |
Why?
|
| Hepatocytes | 4 | 2022 | 196 | 0.370 |
Why?
|
| Liver | 4 | 2022 | 796 | 0.360 |
Why?
|
| PPAR alpha | 2 | 2022 | 29 | 0.340 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 2 | 2018 | 75 | 0.310 |
Why?
|
| N-Methylaspartate | 1 | 2007 | 14 | 0.290 |
Why?
|
| Mice | 24 | 2025 | 10251 | 0.290 |
Why?
|
| Mitogen-Activated Protein Kinase 14 | 1 | 2007 | 8 | 0.280 |
Why?
|
| Insulin Resistance | 4 | 2017 | 392 | 0.270 |
Why?
|
| Apoptosis | 6 | 2019 | 1032 | 0.260 |
Why?
|
| Animals | 26 | 2025 | 19601 | 0.250 |
Why?
|
| Mice, Knockout | 13 | 2022 | 1985 | 0.250 |
Why?
|
| Phosphorylation | 8 | 2025 | 882 | 0.240 |
Why?
|
| Oxidative Stress | 1 | 2007 | 279 | 0.240 |
Why?
|
| Neoplasms | 2 | 2007 | 1240 | 0.240 |
Why?
|
| Gene Expression Profiling | 5 | 2017 | 716 | 0.230 |
Why?
|
| Adipose Tissue | 3 | 2017 | 283 | 0.220 |
Why?
|
| Mice, Inbred C57BL | 9 | 2025 | 3220 | 0.220 |
Why?
|
| Gene Expression Regulation | 5 | 2020 | 1547 | 0.210 |
Why?
|
| Eukaryotic Cells | 1 | 2003 | 57 | 0.200 |
Why?
|
| Inflammation | 3 | 2020 | 1094 | 0.200 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 4 | 2011 | 66 | 0.190 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2003 | 194 | 0.190 |
Why?
|
| Metabolic Syndrome | 1 | 2022 | 131 | 0.180 |
Why?
|
| CLOCK Proteins | 1 | 2020 | 46 | 0.180 |
Why?
|
| Phosphotyrosine | 1 | 2019 | 23 | 0.160 |
Why?
|
| Neurons | 3 | 2018 | 863 | 0.160 |
Why?
|
| Bcl-2-Like Protein 11 | 1 | 2019 | 19 | 0.160 |
Why?
|
| fas Receptor | 1 | 2019 | 55 | 0.150 |
Why?
|
| Spatial Memory | 1 | 2018 | 7 | 0.150 |
Why?
|
| Neutrophils | 1 | 2020 | 353 | 0.150 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2019 | 648 | 0.150 |
Why?
|
| Metabolome | 1 | 2017 | 27 | 0.140 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2019 | 256 | 0.140 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2013 | 583 | 0.140 |
Why?
|
| Caloric Restriction | 1 | 2017 | 16 | 0.140 |
Why?
|
| Mitogen-Activated Protein Kinase Phosphatases | 2 | 2015 | 4 | 0.140 |
Why?
|
| Epigenomics | 1 | 2017 | 54 | 0.130 |
Why?
|
| Neuronal Plasticity | 1 | 2018 | 141 | 0.130 |
Why?
|
| Immunologic Memory | 1 | 2019 | 281 | 0.130 |
Why?
|
| Stress, Physiological | 2 | 2016 | 185 | 0.130 |
Why?
|
| Fibroblasts | 4 | 2011 | 377 | 0.130 |
Why?
|
| Mitogen-Activated Protein Kinase 10 | 1 | 2016 | 12 | 0.130 |
Why?
|
| Somatostatin-Secreting Cells | 1 | 2015 | 8 | 0.120 |
Why?
|
| Glucagon-Secreting Cells | 1 | 2015 | 26 | 0.120 |
Why?
|
| Fetus | 1 | 2015 | 93 | 0.120 |
Why?
|
| Transcriptome | 1 | 2017 | 338 | 0.120 |
Why?
|
| Insulin-Secreting Cells | 1 | 2015 | 178 | 0.110 |
Why?
|
| Islets of Langerhans | 1 | 2015 | 271 | 0.110 |
Why?
|
| Reactive Oxygen Species | 2 | 2019 | 201 | 0.100 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2019 | 635 | 0.100 |
Why?
|
| Cells, Cultured | 6 | 2020 | 2089 | 0.100 |
Why?
|
| MAP Kinase Kinase 4 | 2 | 2022 | 38 | 0.090 |
Why?
|
| RNA | 1 | 2015 | 400 | 0.090 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2015 | 618 | 0.090 |
Why?
|
| Fibroblast Growth Factors | 2 | 2022 | 66 | 0.090 |
Why?
|
| Sirtuin 1 | 1 | 2011 | 25 | 0.090 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2011 | 55 | 0.090 |
Why?
|
| Precancerous Conditions | 1 | 2011 | 70 | 0.090 |
Why?
|
| Fatty Liver | 1 | 2011 | 98 | 0.090 |
Why?
|
| Male | 10 | 2025 | 27727 | 0.080 |
Why?
|
| Enzyme Activation | 5 | 2011 | 358 | 0.080 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2009 | 55 | 0.080 |
Why?
|
| Protein Tyrosine Phosphatases | 2 | 2007 | 57 | 0.070 |
Why?
|
| COS Cells | 1 | 2007 | 173 | 0.070 |
Why?
|
| Lung Neoplasms | 2 | 2011 | 582 | 0.070 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2007 | 70 | 0.070 |
Why?
|
| Cerebellum | 1 | 2007 | 91 | 0.070 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2007 | 116 | 0.070 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2007 | 83 | 0.070 |
Why?
|
| Mice, Transgenic | 2 | 2020 | 1204 | 0.070 |
Why?
|
| Transcription Factor AP-1 | 2 | 2003 | 41 | 0.060 |
Why?
|
| Mice, Nude | 2 | 2004 | 258 | 0.060 |
Why?
|
| Cellular Senescence | 1 | 2006 | 104 | 0.060 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2025 | 21 | 0.060 |
Why?
|
| Dietary Fats | 3 | 2011 | 173 | 0.060 |
Why?
|
| Sequence Analysis, RNA | 2 | 2017 | 159 | 0.060 |
Why?
|
| Muscle, Skeletal | 1 | 2010 | 674 | 0.060 |
Why?
|
| Autocrine Communication | 1 | 2004 | 32 | 0.060 |
Why?
|
| Macrophages, Peritoneal | 1 | 2004 | 73 | 0.060 |
Why?
|
| Humans | 10 | 2025 | 59285 | 0.060 |
Why?
|
| Cell Line | 2 | 2011 | 1968 | 0.050 |
Why?
|
| Point Mutation | 2 | 2018 | 160 | 0.050 |
Why?
|
| Immunity | 1 | 2004 | 100 | 0.050 |
Why?
|
| Transforming Growth Factor beta | 1 | 2004 | 167 | 0.050 |
Why?
|
| RNA-Binding Proteins | 1 | 2006 | 384 | 0.050 |
Why?
|
| Lymphocyte Activation | 2 | 2004 | 743 | 0.050 |
Why?
|
| Lymphocytic choriomeningitis virus | 2 | 2019 | 88 | 0.050 |
Why?
|
| Retinoid X Receptor alpha | 1 | 2022 | 6 | 0.050 |
Why?
|
| Neoplasms, Experimental | 1 | 2003 | 75 | 0.050 |
Why?
|
| Energy Metabolism | 1 | 2025 | 359 | 0.050 |
Why?
|
| Sex Factors | 1 | 2025 | 935 | 0.050 |
Why?
|
| In Vitro Techniques | 1 | 2003 | 469 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2002 | 98 | 0.050 |
Why?
|
| Rats | 2 | 2019 | 1909 | 0.050 |
Why?
|
| Cell Line, Tumor | 2 | 2019 | 1368 | 0.050 |
Why?
|
| Enzyme Inhibitors | 1 | 2003 | 349 | 0.050 |
Why?
|
| MAP Kinase Signaling System | 2 | 2018 | 202 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2002 | 318 | 0.040 |
Why?
|
| Neutropenia | 1 | 2020 | 62 | 0.040 |
Why?
|
| Insulin | 2 | 2017 | 674 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2019 | 2046 | 0.040 |
Why?
|
| T-Lymphocytes | 1 | 2004 | 983 | 0.040 |
Why?
|
| Glucose | 2 | 2015 | 445 | 0.040 |
Why?
|
| src-Family Kinases | 1 | 2019 | 60 | 0.040 |
Why?
|
| Arenaviridae Infections | 1 | 2019 | 15 | 0.040 |
Why?
|
| Immunity, Innate | 1 | 2004 | 765 | 0.040 |
Why?
|
| Conditioning, Classical | 1 | 2018 | 5 | 0.040 |
Why?
|
| Skin Transplantation | 1 | 2019 | 155 | 0.040 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2019 | 171 | 0.040 |
Why?
|
| Fatty Acids | 1 | 2019 | 190 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2022 | 696 | 0.040 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2009 | 170 | 0.040 |
Why?
|
| Proteomics | 1 | 2019 | 263 | 0.040 |
Why?
|
| Protein Interaction Mapping | 1 | 2017 | 68 | 0.040 |
Why?
|
| Anaerobiosis | 1 | 2017 | 15 | 0.030 |
Why?
|
| Circadian Rhythm | 1 | 2020 | 373 | 0.030 |
Why?
|
| Glycolysis | 1 | 2017 | 54 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2019 | 868 | 0.030 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2011 | 289 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2017 | 146 | 0.030 |
Why?
|
| Nutritional Status | 1 | 2017 | 93 | 0.030 |
Why?
|
| Agouti-Related Protein | 1 | 2016 | 6 | 0.030 |
Why?
|
| Hippocampus | 1 | 2018 | 246 | 0.030 |
Why?
|
| Homeostasis | 1 | 2019 | 346 | 0.030 |
Why?
|
| Hyperphagia | 1 | 2016 | 18 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2017 | 393 | 0.030 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2015 | 34 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 2 | 2007 | 53 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2017 | 357 | 0.030 |
Why?
|
| Cell Cycle | 2 | 2006 | 382 | 0.030 |
Why?
|
| Cell Division | 2 | 2004 | 443 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 9 | 2 | 2003 | 39 | 0.030 |
Why?
|
| Interleukin-6 | 2 | 2004 | 308 | 0.020 |
Why?
|
| Contact Inhibition | 1 | 2011 | 3 | 0.020 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2011 | 16 | 0.020 |
Why?
|
| Gene Knockout Techniques | 1 | 2011 | 86 | 0.020 |
Why?
|
| Histone Deacetylases | 1 | 2011 | 62 | 0.020 |
Why?
|
| Ubiquitination | 1 | 2011 | 106 | 0.020 |
Why?
|
| Cadherins | 1 | 2011 | 69 | 0.020 |
Why?
|
| Recombinant Proteins | 2 | 2003 | 688 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2015 | 1782 | 0.020 |
Why?
|
| Female | 2 | 2025 | 30696 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2010 | 182 | 0.020 |
Why?
|
| Macrophages | 1 | 2015 | 1000 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2009 | 188 | 0.020 |
Why?
|
| Pancreas | 1 | 2009 | 147 | 0.020 |
Why?
|
| Proteome | 1 | 2009 | 141 | 0.020 |
Why?
|
| Pregnancy | 1 | 2015 | 2202 | 0.020 |
Why?
|
| Feedback, Physiological | 1 | 2007 | 59 | 0.020 |
Why?
|
| Tumor Suppressor Protein p14ARF | 1 | 2006 | 12 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2011 | 940 | 0.020 |
Why?
|
| Base Sequence | 1 | 2009 | 1300 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2006 | 51 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2007 | 188 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2006 | 96 | 0.020 |
Why?
|
| mRNA Cleavage and Polyadenylation Factors | 1 | 2006 | 61 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2009 | 1552 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2009 | 1949 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2006 | 583 | 0.020 |
Why?
|
| Young Adult | 1 | 2015 | 4266 | 0.020 |
Why?
|
| Dual-Specificity Phosphatases | 1 | 2004 | 7 | 0.010 |
Why?
|
| Receptor Cross-Talk | 1 | 2004 | 10 | 0.010 |
Why?
|
| Activin Receptors, Type I | 1 | 2004 | 14 | 0.010 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2004 | 29 | 0.010 |
Why?
|
| Bromodeoxyuridine | 1 | 2004 | 40 | 0.010 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2004 | 64 | 0.010 |
Why?
|
| Genes, Dominant | 1 | 2004 | 55 | 0.010 |
Why?
|
| Adolescent | 1 | 2015 | 5822 | 0.010 |
Why?
|
| Jurkat Cells | 1 | 2004 | 103 | 0.010 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2004 | 53 | 0.010 |
Why?
|
| Homozygote | 1 | 2004 | 114 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 2006 | 297 | 0.010 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2004 | 57 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2006 | 384 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2004 | 250 | 0.010 |
Why?
|
| Activating Transcription Factor 2 | 1 | 2003 | 12 | 0.010 |
Why?
|
| Wound Healing | 1 | 2004 | 174 | 0.010 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2003 | 46 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2004 | 292 | 0.010 |
Why?
|
| bcl-2 Homologous Antagonist-Killer Protein | 1 | 2002 | 11 | 0.010 |
Why?
|
| MAP Kinase Kinase 7 | 1 | 2002 | 9 | 0.010 |
Why?
|
| Cytochrome c Group | 1 | 2002 | 24 | 0.010 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2002 | 42 | 0.010 |
Why?
|
| Cell Movement | 1 | 2004 | 428 | 0.010 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2002 | 25 | 0.010 |
Why?
|
| Receptors, Interleukin | 1 | 2002 | 39 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2004 | 324 | 0.010 |
Why?
|
| Protein Binding | 1 | 2006 | 1554 | 0.010 |
Why?
|
| Inflammation Mediators | 1 | 2003 | 168 | 0.010 |
Why?
|
| Caspase 3 | 1 | 2002 | 103 | 0.010 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2002 | 69 | 0.010 |
Why?
|
| Ultraviolet Rays | 1 | 2002 | 127 | 0.010 |
Why?
|
| Interleukin-2 | 1 | 2002 | 164 | 0.010 |
Why?
|
| Cricetinae | 1 | 2002 | 365 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2004 | 650 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 2004 | 626 | 0.010 |
Why?
|
| Caspases | 1 | 2002 | 166 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 2002 | 214 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2006 | 1464 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 2003 | 551 | 0.010 |
Why?
|
| Influenza A virus | 1 | 2002 | 116 | 0.010 |
Why?
|
| Spleen | 1 | 2002 | 480 | 0.010 |
Why?
|
| Gene Expression | 1 | 2003 | 808 | 0.010 |
Why?
|
| Mitochondria | 1 | 2002 | 343 | 0.010 |
Why?
|
| Adult | 1 | 2015 | 15664 | 0.010 |
Why?
|
| Middle Aged | 1 | 2015 | 16311 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2002 | 846 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2003 | 1470 | 0.010 |
Why?
|
| Time Factors | 1 | 2002 | 3614 | 0.010 |
Why?
|